Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

Distinguishing between follicular thyroid cancer (FTC) and follicular thyroid adenoma (FTA) constitutes a long-standing diagnostic problem resulting in equivocal histopathological diagnoses. There is therefore a need for additional molecular markers. To identify molecular differences between FTC and FTA, we analyzed the gene expression microarray data of 52 follicular neoplasms. We also performed a meta-analysis involving 14 studies employing high throughput methods (365 follicular neoplasms analyzed). Based on these two analyses, we selected 18 genes differentially expressed between FTA and FTC. We validated them by quantitative real-time polymerase chain reaction (qRT-PCR) in an independent set of 71 follicular neoplasms from formaldehyde-fixed paraffin embedded (FFPE) tissue material. We confirmed differential expression for 7 genes (CPQ, PLVAP, TFF3, ACVRL1, ZFYVE21, FAM189A2, and CLEC3B). Finally, we created a classifier that distinguished between FTC and FTA with an accuracy of 78%, sensitivity of 76%, and specificity of 80%, based on the expression of 4 genes (CPQ, PLVAP, TFF3, ACVRL1). In our study, we have demonstrated that meta-analysis is a valuable method for selecting possible molecular markers. Based on our results, we conclude that there might exist a plausible limit of gene classifier accuracy of approximately 80%, when follicular tumors are discriminated based on formalin-fixed postoperative material.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Kikuya Kato,et al.  Differentiation of Follicular Thyroid Adenoma from Carcinoma by Means of Gene Expression Profiling with Adapter-Tagged Competitive Polymerase Chain Reaction , 2005, Oncology.

[3]  M. Nagano,et al.  The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia , 2013, PloS one.

[4]  R. Parameswaran,et al.  Molecular pathogenesis of follicular cell derived thyroid cancers. , 2010, International journal of surgery.

[5]  Jennifer Shoemaker,et al.  A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. , 2004, The Journal of clinical investigation.

[6]  R. Vassilopoulou-sellin,et al.  Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. , 1998, The American journal of surgical pathology.

[7]  G. Lozano,et al.  Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. , 2011, Human pathology.

[8]  N. Eberhardt,et al.  PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. , 2005, The Journal of clinical endocrinology and metabolism.

[9]  R. Paschke,et al.  Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling. , 2013, Endokrynologia Polska.

[10]  S. Liyanarachchi,et al.  Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Z. Baloch,et al.  Follicular-Patterned Tumors of the Thyroid: The Battle of Benign vs. Malignant vs. So-called Uncertain , 2011, Endocrine pathology.

[12]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  T. Fahey,et al.  Molecular analysis of minimally invasive follicular carcinomas by gene profiling. , 2005, Surgery.

[14]  Anne-Laure Boulesteix,et al.  CMA – a comprehensive Bioconductor package for supervised classification with high dimensional data , 2008, BMC Bioinformatics.

[15]  Ed Y. Tom,et al.  Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules? , 2013, The Journal of clinical endocrinology and metabolism.

[16]  Philippe Vielh,et al.  Gene Expression Profiling of Differentiated Thyroid Neoplasms , 2004, Clinical Cancer Research.

[17]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[18]  F. Bertucci,et al.  Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  Olivier Elemento,et al.  A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration , 2012, Clinical Cancer Research.

[20]  A. Miyauchi,et al.  Gene expression profiles in thyroid carcinomas , 2000, British Journal of Cancer.

[21]  F. Fang,et al.  The Expression of Activin Receptor–Like Kinase 1 among Patients with Head and Neck Cancer , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[22]  C. Barden,et al.  Classification of follicular thyroid tumors by molecular signature: results of gene profiling. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  T. Fahey.  Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination , 2006 .

[24]  Adam L. Asare,et al.  Power enhancement via multivariate outlier testing with gene expression arrays , 2009, Bioinform..

[25]  Richard Simon,et al.  Bias in error estimation when using cross-validation for model selection , 2006, BMC Bioinformatics.

[26]  T. Takano,et al.  High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas , 2004, British Journal of Cancer.

[27]  L. Adan,et al.  Use of molecular markers in samples obtained from preoperative aspiration of thyroid. , 2012, Endocrine journal.

[28]  B. Wojtaś,et al.  Somatic mutation profiling of follicular thyroid cancer by next generation sequencing , 2016, Molecular and Cellular Endocrinology.

[29]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[30]  Holger Moch,et al.  Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. , 2008, Oncology reports.

[31]  R. Paschke,et al.  Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues , 2013, BMC Medical Genomics.

[32]  Hanna Göransson,et al.  Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors , 2006, Tumor Biology.

[33]  A. Vargas,et al.  Tumor Heterogeneity in a Follicular Carcinoma of Thyroid: a Study by Comparative Genomic Hybridization , 2011, Endocrine pathology.

[34]  M. Yamashina,et al.  Follicular Neoplasms of the Thyroid: Total Circumferential Evaluation of the Fibrous Capsule , 1992, The American journal of surgical pathology.

[35]  Eric T. Wang,et al.  Molecular classification of thyroid nodules using high-dimensionality genomic data. , 2010, The Journal of clinical endocrinology and metabolism.

[36]  E. J. Neves,et al.  Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression , 2006, Cancer.

[37]  M. Hansmann,et al.  QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study , 2009, BMC Cancer.

[38]  A. Gill,et al.  Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas , 2003 .

[39]  Ricardo Henao,et al.  Molecular signatures of thyroid follicular neoplasia. , 2010, Endocrine-related cancer.

[40]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[41]  Krzysztof Fujarewicz,et al.  Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.

[42]  S. Chevret,et al.  Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. , 2003, Human pathology.

[43]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[44]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.